These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8403910)

  • 41. Variable effects of RU 486 on endometrial maintenance in the luteal phase extended by exogenous hCG.
    Croxatto HB; Salvatierra AM; Croxatto HD; Spitz IM
    Clin Endocrinol (Oxf); 1989 Jul; 31(1):15-23. PubMed ID: 2598478
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Early luteal phase treatment with mifepristone (RU 486) for fertility regulation.
    Gemzell-Danielsson K; Swahn ML; Svalander P; Bygdeman M
    Hum Reprod; 1993 Jun; 8(6):870-3. PubMed ID: 8345076
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pre-operative cervical preparation before first trimester vacuum aspiration: a randomized controlled comparison between gemeprost and mifepristone (RU 486).
    Henshaw RC; Templeton AA
    Br J Obstet Gynaecol; 1991 Oct; 98(10):1025-30. PubMed ID: 1751434
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacokinetics and metabolism of RU 486.
    Lähteenmäki P; Heikinheimo O; Croxatto H; Spitz I; Shoupe D; Birgerson L; Luukkainen T
    J Steroid Biochem; 1987; 27(4-6):859-63. PubMed ID: 3695508
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Distribution of RU 486 and its demethylated metabolites in humans.
    Heikinheimo O; Haukkamaa M; Lähteenmäki P
    J Clin Endocrinol Metab; 1989 Feb; 68(2):270-5. PubMed ID: 2918046
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A study of gemeprost alone, dilapan or mifepristone in combination with gemeprost for the termination of second trimester pregnancy.
    Thong KJ; Baird DT
    Contraception; 1992 Jul; 46(1):11-7. PubMed ID: 1424619
    [TBL] [Abstract][Full Text] [Related]  

  • 47. RU 486: a steroid with antiglucocorticosteroid activity that only disinhibits the human pituitary-adrenal system at a specific time of day.
    Gaillard RC; Riondel A; Muller AF; Herrmann W; Baulieu EE
    Proc Natl Acad Sci U S A; 1984 Jun; 81(12):3879-82. PubMed ID: 6328529
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effect of antiprogestin (RU 486) and prostaglandin biosynthesis inhibitor (naproxen) on uterine fluid prostaglandin F2 alpha concentrations.
    Gemzell-Danielsson K; Hamberg M
    Hum Reprod; 1994 Sep; 9(9):1626-30. PubMed ID: 7836511
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Early pregnancy termination: a comparison between vacuum aspiration and medical abortion using prostaglandin (16,16 dimethyl-trans-delta 2-PGE1 methyl ester) or the antiprogestogen RU 486.
    Cameron IT; Baird DT
    Br J Obstet Gynaecol; 1988 Mar; 95(3):271-6. PubMed ID: 3370199
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Once-a-month treatment with a combination of mifepristone and the prostaglandin analogue misoprostol.
    Swahn ML; Bygdeman M; Chen JK; Gemzell-Danielsson K; Song S; Yang QY; Yang PJ; Qian ML; Chang WF
    Hum Reprod; 1999 Feb; 14(2):485-8. PubMed ID: 10099999
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Blood loss following induction of early abortion using mifepristone (RU 486) and a prostaglandin analogue (gemeprost).
    Rodger MW; Baird DT
    Contraception; 1989 Oct; 40(4):439-47. PubMed ID: 2582769
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of different doses of norethisterone on ovarian function, serum sex hormone binding globulin and high density lipoprotein-cholesterol.
    Song S; Chen JK; Lu CH; Yang PJ; Yang QY; Fan BC; He ML; Gui YL; Li LM; Fotherby K
    Contraception; 1993 Jun; 47(6):527-37. PubMed ID: 8334889
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Administration of RU 486 for 8 days in normal volunteers: antiglucocorticoid effect with no evidence of peripheral cortisol deprivation.
    Bertagna X; Escourolle H; Pinquier JL; Coste J; Raux-Demay MC; Perles P; Silvestre L; Luton JP; Strauch G
    J Clin Endocrinol Metab; 1994 Feb; 78(2):375-80. PubMed ID: 8106625
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Contraceptive efficacy of low doses of mifepristone.
    Marions L; Danielsson KG; Swahn ML; Bygdeman M
    Fertil Steril; 1998 Nov; 70(5):813-6. PubMed ID: 9806558
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Quantitation of RU 486 in human plasma by HPLC and RIA after column chromatography.
    Heikinheimo O; Tevilin M; Shoupe D; Croxatto H; Lähteenmäki P
    Contraception; 1986 Dec; 34(6):613-24. PubMed ID: 3829676
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antigestogens.
    Baird DT
    Br Med Bull; 1993 Jan; 49(1):73-87. PubMed ID: 8324617
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Medical termination of early pregnancy with mifepristone (RU 486) followed by a prostaglandin analogue. Study in 16,369 women.
    Ulmann A; Silvestre L; Chemama L; Rezvani Y; Renault M; Aguillaume CJ; Baulieu EE
    Acta Obstet Gynecol Scand; 1992 May; 71(4):278-83. PubMed ID: 1322621
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of chronic treatment with the glucocorticoid antagonist RU 486 in man: toxicity, immunological, and hormonal aspects.
    Laue L; Lotze MT; Chrousos GP; Barnes K; Loriaux DL; Fleisher TA
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1474-80. PubMed ID: 2172280
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Interference with ovulation by sequential treatment with the antiprogesterone RU486 and synthetic progestin.
    Kekkonen R; Alfthan H; Haukkamaa M; Heikinheimo O; Luukkainen T; Lähteenmäki P
    Fertil Steril; 1990 Apr; 53(4):747-50. PubMed ID: 2108063
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Preliminary report on the treatment of endometriosis with low-dose mifepristone (RU 486).
    Kettel LM; Murphy AA; Morales AJ; Yen SS
    Am J Obstet Gynecol; 1998 Jun; 178(6):1151-6. PubMed ID: 9662295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.